Form Type: 4

SEC EDGAR Link
Acccession Number:0001237899-19-000012
Date:2019-05-13
Issuer: REGENERON PHARMACEUTICALS INC (REGN)
Original Submission Date:

Reporting Person:

STAHL NEIL
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-05-13 M 25,000 a $52.03 47,450 direct
COMMON STOCK 2019-05-13 F 15,147 d $304.20 32,303 direct
COMMON STOCK 2019-05-14 S 6,575 d $305.43 25,728 direct
COMMON STOCK 2019-05-14 S 3,278 d $306.37 22,450 direct
COMMON STOCK 0 $0.00 5,731 indirect
COMMON STOCK 0 $0.00 16,500 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 52.03 2019-05-13 deemed execution date M 25,000 (d) 2021-12-16 common stock 25,000 $52.03 98,079 direct
Footnotes
IDfootnote
f1 represents volume-weighted average price of sales of 6,575 shares of company stock on may 14, 2019 at prices ranging from $305.05 to $305.98. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on may 14, 2019 at each separate price.
f2 represents volume-weighted average price of sales of 3,278 shares of company stock on may 14, 2019 at prices ranging from $306.00 to $306.76. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on may 14, 2019 at each separate price.
f3 with respect to 75,000 underlying shares, the option became exercisable on december 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended december 31, 2014. with respect to 48,079 underlying shares, the stock option award vested in four equal annual installments, commencing one year after the date of grant.

Elevate your investments